Found: 7
Select item for more details and to access through your institution.
Retraction statement: Dual targeting of RANKL and PD‐1 with a bispecific antibody improves anti‐tumor immunity.
- Published in:
- 2022
- Publication type:
- Correction Notice
Epigenetic regulation of inflammation by microRNAs in post‐infectious bronchiolitis obliterans.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1376
- By:
- Publication type:
- Article
Optimising the IgG‐degrading enzyme treatment regimen for enhanced adeno‐associated virus transduction in the presence of neutralising antibodies.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1375
- By:
- Publication type:
- Article
Inflammatory marker trajectories associated with frailty and ageing in a 20‐year longitudinal study.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1374
- By:
- Publication type:
- Article
Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1373
- By:
- Publication type:
- Article
Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1370
- By:
- Publication type:
- Article
Quantitative measurement of IgG to SARS‐CoV‐2 antigens using monoclonal antibody‐based enzyme‐linked immunosorbent assays.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1369
- By:
- Publication type:
- Article